Cardiac outflow tract septation failure in Pax3-deficient embryos is due to p53-dependent regulation of migrating cardiac neural crest

Mechanisms of Development

Volumn 125, Issue 9-10, 2008, Pages 757-767

  Morgan, Sarah C ^a   Lee, Hyung Yul ^a   Relaix, Frédéric ^b   Sandell, Lisa L ^c   Levorse, John M ^d   Loeken, Mary R ^a  

^a JOSLIN DIABETES CENTER   (United States)

^b INSERM   (France)

^c STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d PRINCETON UNIVERSITY   (United States)

Author keywords

Apoptosis; Cardiac neural crest; Cardiac outflow tract; Congenital defect; p53; Pax3

Indexed keywords

PIFITHRIN ALPHA; PROTEIN P53; TRANSCRIPTION FACTOR PAX3;

ARTICLE; CELL DEATH; CELL MIGRATION; CONTROLLED STUDY; GENE EXPRESSION; GENE MAPPING; GENE REPRESSION; GENOTYPE; HEART FAILURE; MOUSE; NEURAL CREST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; BENZOTHIAZOLES; CELL MOVEMENT; CROSSES, GENETIC; EMBRYO, MAMMALIAN; FEMALE; GENOTYPE; HEART; MALE; MICE; MYOCARDIUM; NEURAL CREST; PAIRED BOX TRANSCRIPTION FACTORS; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 51149095224     PISSN: 09254773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mod.2008.07.003     Document Type: Article

References (57)

1. Anderson D.J. Cellular and molecular biology of neural crest cell lineage determination. Trends Genet. 13 (1997) 276-280
2. Auerbach R. Analysis of the developmental effects of a lethal mutation in the house mouse. J. Exp. Zoolog. 127 (1954) 305-329
3. Banerjee A.K. Waardenburg's syndrome associated with ostium secundum atrial septal defect. J. R. Soc. Med. 79 (1986) 677-678
4. Besson W.T., Kirby M.L., Mierop L.H.V., and Teabeaut J.R. Effects of the size of lesions of the cardiac neural crest at various embryonic ages on incidence and type of cardiac defects. Circulation 73 (1986) 360-364
5. Bober E., Franz T., Arnold H.H., Gruss P., and Tremblay P. Pax-3 is required for the development of limb muscles: a possible role for the migration of dermomyotomal muscle progenitor cells. Development 120 (1994) 603-612
6. Bockman D.E., Redmond M.E., Waldo K., Davis H., and Kirby M.L. Effect of neural crest ablation on development of the heart and arch arteries in the chick. Am. J. Anat. 180 (1987) 332-341
7. Bursch W., Paffe S., Putz B., Barthel G., and Schulte-Hermann R. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis 11 (1990) 847-853
8. Cai J., Phelan S.A., Hill A.L., and Loeken M.R. Identification of Dep-1, a new gene regulated by the transcription factor Pax-3, as a marker for altered embryonic gene expression during diabetic pregnancy. Diabetes 47 (1998) 1803-1805
9. Chalepakis G., Goulding M., Read A., Strachan T., and Gruss P. Molecular basis of splotch and Waardenburg Pax-3 mutations. Proc. Natl. Acad. Sci. USA 91 (1994) 3685-3689
10. Chan W.Y., Cheung C.S., Yung K.M., and Copp A.J. Cardiac neural crest of the mouse embryo: axial level of origin, migratory pathway and cell autonomy of the splotch (Sp2H) mutant effect. Development 131 (2004) 3367-3379
11. Conway S.J., Bundy J., Chen J., Dickman E., Rogers R., and Will B.M. Decreased neural crest stem cell expansion is responsible for the conotruncal heart defects within the splotch (Sp(2H))/Pax3 mouse mutant. Cardiovasc. Res. 47 (2000) 314-328
12. Conway S.J., Godt R.E., Hatcher C.J., Leatherbury L., Zolotouchnikov V.V., Brotto M.A., Copp A.J., Kirby M.L., and Creazzo T.L. Neural crest is involved in development of abnormal myocardial function. J. Mol. Cell. Cardiol. 29 (1997) 2675-2685
13. Conway S.J., Henderson D.J., and Copp A.J. Pax3 is required for cardiac neural crest migration in the mouse: evidence from the splotch (Sp2H) mutant. Development 124 (1997) 505-514
14. Creazzo T.L., Godt R.E., Leatherbury L., Conway S.J., and Kirby M.L. Role of cardiac neural crest cells in cardiovascular development. Annu. Rev. Physiol. 60 (1998) 267-286
15. Dameron K.M., Volpert O.V., Tainsky M.A., and Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265 (1994) 1582-1584
16. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery Jr. C.A., Butel J.S., and Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356 (1992) 215-221
17. Dorsky R.I., Moon R.T., and Raible D.W. Control of neural crest cell fate by the Wnt signalling pathway. Nature 396 (1998) 370-373
18. Endo H., Saito A., and Chan P.H. Mitochondrial translocation of p53 underlies the selective death of hippocampal CA1 neurons after global cerebral ischaemia. Biochem. Soc. Trans. 34 (2006) 1283-1286
19. Epstein D.J., Vekemans M., and Gros P. Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 67 (1991) 767-774
20. Epstein D.J., Vogan K.J., Trasler D.G., and Gros P. A mutation within intron 3 of the Pax-3 gene produces aberrantly spliced mRNA transcripts in the splotch (Sp) mouse mutant. Proc. Natl. Acad. Sci. USA 90 (1993) 532-536
21. Epstein J.A., Li J., Lang D., Chen F., Brown C.B., Jin F., Lu M.M., Thomas M., Liu E., Wessels A., and Lo C.W. Migration of cardiac neural crest cells in Splotch embryos. Development 127 (2000) 1869-1870
22. Epstein J.A., Shapiro D.N., Cheng J., Lam P.Y., and Maas R.L. Pax3 modulates expression of the c-Met receptor during limb muscle development. Proc. Natl. Acad. Sci. USA 93 (1996) 4213
23. Franz T. Persistent truncus arteriosus in the Splotch mutant mouse. Anat. Embryol. (Berl) 180 (1989) 457-464
24. Gary R.K., and Jensen D.A. The p53 inhibitor pifithrin-alpha forms a sparingly soluble derivative via intramolecular cyclization under physiological conditions. Mol. Pharm. 2 (2005) 462-474
25. Hill A.L., Phelan S.A., and Loeken M.R. Reduced expression of pax-3 is associated with overexpression of cdc46 in the mouse embryo. Dev. Genes Evol. 208 (1998) 128-134
26. Ikeya M., Lee S.M., Johnson J.E., McMahon A.P., and Takada S. Wnt signalling required for expansion of neural crest and CNS progenitors. Nature 389 (1997) 966-970
27. Jacks T., Remington L., William B.O., Schmitt E.M., Halachmi S., Bronson R.T., and Weinberg R.A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4 (1994) 1-7
28. Jiang X., Rowitch D.H., Soriano P., McMahon A.P., and Sucov H.M. Fate of the mammalian cardiac neural crest. Development 127 (2000) 1607-1616
29. Kamijo T., Weber J.D., Zambetti G., Zindy F., Roussel M.F., and Sherr C.J. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. USA 95 (1998) 8292-8297
30. Kaufman M.H. The Atlas of Mouse Development (1992), Academic Press, San Diego, CA
31. Kioussi C., Gross M.K., and Gruss P. Pax3: a paired domain gene as a regulator in PNS myelination. Neuron 15 (1995) 55-62
32. Kirby M.L. Cardiac morphogenesis-recent research advances. Pediatr. Res. 21 (1987) 219-224
33. Kirby M.L., Gale T.F., and Stewart D.E. Neural crest cells contribute to normal aorticopulmonary septation. Science 220 (1983) 1059-1061
34. Komarov P.G., Komarova E.A., Kondratov R.V., Christov-Tselkov K., Coon J.S., Chernov M.V., and Gudkov A.V. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285 (1999) 1733-1737
35. Kwang S.J., Brugger S.M., Lazik A., Merrill A.E., Wu L.Y., Liu Y.H., Ishii M., Sangiorgi F.O., Rauchman M., Sucov H.M., Maas Jr. R.L., and R.E.M. Msx2 is an immediate downstream effector of Pax3 in the development of the murine cardiac neural crest. Development 129 (2002) 527-538
36. Lalwani A.K., Brister J.R., Fex J., Grundfast K.M., Ploplis B., Agustin T.B.S., and Wilcox E.R. Further elucidation of the genomic structure of PAX3, and identification of two different point mutations within the PAX3 homeobox that cause Waardenburg syndrome type 1 in two families. Am. J. Hum. Genet. 56 (1995) 75-83
37. Li J., Liu K.C., Jin F., Lu M.M., and Epstein J.A. Transgenic rescue of congenital heart disease and spina bifida in Splotch mice. Development 126 (1999) 2495-2503
38. Linke S.P., Clarkin K.C., Di Leonardo A., Tsou A., and Wahl G.M. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10 (1996) 934-947
39. Markel P., Shu P., Ebeling C., Carlson G.A., Nagle D.L., Smutko J.S., and Moore K.J. Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains. Nat. Genet. 17 (1997) 280-284
40. Maroto M., Reshef R., Munsterberg A.E., Koester S., Goulding M., and Lassar A.B. Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue. Cell 89 (1997) 139-148
41. Mathieu M., Bourges E., Caron F., and Piussan C. Waardenburg's syndrome and severe cyanotic cardiopathy. Arch. Fr. Pediatr. 47 (1990) 657-659
42. Moase C.E., and Trasler D.G. Delayed neural crest cell emigration from Sp and Spd mouse neural tube explants. Teratology 42 (1990) 171-182
43. Murphy P.J., Galigniana M.D., Morishima Y., Harrell J.M., Kwok R.P., Ljungman M., and Pratt W.B. Pifithrin-alpha inhibits p53 signaling after interaction of the tumor suppressor protein with hsp90 and its nuclear translocation. J. Biol. Chem. 279 (2004) 30195-30201
44. Nishibatake M., Kirby M.L., and Mierop L.H.V. Pathogenesis of persistent truncus arteriosus and dextroposed aorta in the chick embryo after neural crest ablation. Circulation 75 (1987) 255-264
45. Pani L., Horal M., and Loeken M.R. Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3- dependent development and tumorigenesis. Genes Dev. 16 (2002) 676-680
46. Parr B.A., Shea M.J., Vassileva G., and McMahon A.P. Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb buds. Development 119 (1993) 247-261
47. Phelan S.A., Ito M., and Loeken M.R. Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 46 (1997) 1189-1197
48. Phelan S.A., and Loeken M.R. Identification of a new binding motif for the paired domain of Pax-3 and unusual characteristics of spacing of bipartite recognition elements on binding and transcription activation. J. Biol. Chem. 273 (1998) 19153-19159
49. Relaix F., Polimeni M., Rocancourt D., Ponzetto C., Schafer B.W., and Buckingham M. The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo. Genes Dev. 17 (2003) 2950-2965
50. Robson E.J.D., He S.-J., and Eccles M.R. A PANorama of PAX genes in cancer and development. Nat. Rev. Cancer 6 (2006) 52-62
51. Rodriguez M., and Schaper J. Apoptosis: measurement and technical issues. J. Mol. Cell. Cardiol. 38 (2005) 15-20
52. Roger L., Gadea G., and Roux P. Control of cell migration: a tumour suppressor function for p53?. Biol. Cell 98 (2006) 141-152
53. Sauka-Spengler T., and Bronner-Fraser M. Development and evolution of the migratory neural crest: a gene regulatory perspective. Curr. Opin. Genet. Dev. 16 (2006) 360-366
54. Snider P., Olaopa M., Firulli A.B., and Conway S.J. Cardiovascular development and the colonizing cardiac neural crest lineage. ScientificWorldJournal 7 (2007) 1090-1113
55. Tajbakhsh S., Rocancourt D., Cossu G., and Buckingham M. Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell 89 (1997) 127-138
56. Vogan K.J., Epstein D.J., Trasler D.G., and Gros P. The splotch-delayed (Spd) mouse mutant carries a point mutation within the paired box of the Pax-3 gene. Genomics 17 (1993) 364-369
57. Wakeland E., Morel L., Achey K., Yui M., and Longmate J. Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol. Today 18 (1997) 472-477